Department of Pulmonology, University Hospital of Nancy, 9 Rue du Morvan, 54511, Vandoeuvre-lès-Nancy, France; Development, Adaptation and Disadvantage, Cardiorespiratory Regulations and Motor Control (EA 3450 DevAH) Research Unit, University of Lorraine, 9 Avenue de la Forêt de Haye, 54505, Vandoeuvre-lès-Nancy, France.
Development, Adaptation and Disadvantage, Cardiorespiratory Regulations and Motor Control (EA 3450 DevAH) Research Unit, University of Lorraine, 9 Avenue de la Forêt de Haye, 54505, Vandoeuvre-lès-Nancy, France; Lung Function Testing Lab, Children's University Hospital, 8 Rue du Morvan, 54511, Vandoeuvre-lès-Nancy, France.
Respir Med. 2021 Apr;179:106329. doi: 10.1016/j.rmed.2021.106329. Epub 2021 Feb 12.
The hyperventilation syndrome (HVS) is characterized by somatic/ psychological symptoms due to sustained hypocapnia and respiratory alkalosis without any organic disease.
The purpose of this study was to compare ventilatory parameters and symptoms reproducibility during the hyperventilation provocation test (HVPT) and cardiopulmonary exercise test (CPET) as diagnostic tools in patients with HVS, and to identify the most frequent etiologies of the HVS by a systematic assessment.
After exclusion of organic causes, 59 patients with HVS according to Nijmegen's questionnaire (NQ) score ≥23 with associated hypocapnia (PaCO/PET<35 mm Hg) were studied.
The most frequent comorbidities of HVS were anxiety and asthma (respectively 95% and 73% of patients). All patients described ≥3 symptoms of NQ during the HVPT vs 14% of patients during the CPET (p<0.01). For similar maximal ventilation (61 L/min during HVPT vs 60 L/min during CPET), the median level of PET decreased from 30 mmHg at baseline to 15 mmHg during hyperventilation and increased from 31 mmHg at baseline to 34 mmHg at peak exercise (all p<0.01). No significant difference for the ventilatory parameters was found between patients with HVS (n = 16) and patients with HVS + asthma (n = 43).
In term of symptoms reproducibility, HVPT is a better diagnostic tool than CPET for HVS. An important proportion of patients with HVS has an atypical asthma previously misdiagnosed. The exercise-induced hyperventilation did not induce abnormal reduction in PET, suggesting that the exercise could be a therapeutic tool in HVS.
过度通气综合征(HVS)的特征是由于持续低碳酸血症和呼吸性碱中毒而导致的躯体/心理症状,而无任何器质性疾病。
本研究旨在比较过度通气激发试验(HVPT)和心肺运动试验(CPET)作为诊断工具在 HVS 患者中的通气参数和症状重现性,并通过系统评估确定 HVS 最常见的病因。
在排除器质性原因后,根据尼梅根问卷(NQ)评分≥23 分且伴有低碳酸血症(PaCO2/PET<35mmHg)的 59 例 HVS 患者进行研究。
HVS 最常见的合并症是焦虑和哮喘(分别为 95%和 73%的患者)。所有患者在 HVPT 期间描述了≥3 项 NQ 症状,而在 CPET 期间仅 14%的患者描述了这些症状(p<0.01)。对于相似的最大通气量(HVPT 时为 61L/min,CPET 时为 60L/min),PET 的中位数水平从基线时的 30mmHg 下降到过度通气时的 15mmHg,并从基线时的 31mmHg 增加到峰值运动时的 34mmHg(均p<0.01)。在 HVS 患者(n=16)和 HVS+哮喘患者(n=43)之间,通气参数没有显著差异。
就症状重现性而言,HVPT 是 HVS 的一种更好的诊断工具。有相当一部分 HVS 患者存在先前误诊的非典型哮喘。运动引起的过度通气并未导致 PET 异常降低,提示运动可能是 HVS 的一种治疗工具。